ESMO 2023 Insights: "CodeBreak 300 Phase 3 Study - Sotorasib & Panitumumab in KRAS G12Cm mCRC" | VuMedi

Find latest Non-Small Cell Lung Cancer videos · 600+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

ecancer

ESMO 2023 Insights: "CodeBreak 300 Phase 3 Study - Sotorasib & Panitumumab in KRAS G12Cm mCRC"

By ecancer FEATURING Filippo Pietrantonio

By ecancer FEATURING Filippo Pietrantonio

269 views

October 27, 2023

Comments 0

Login to view comments. Click here to Login